73 Live Notices for Erythropoietin Tenders
Showing 1 to 20
* Price Register * Erythropoietin 2000 Iu Injectable Solution 1 Ml Vial, Clomiphene Citrate 50 Mg Tablet, Desmopressin Acetate 0.1 Mg/Ml Solution 2.5 Ml Vial, Cisplatin 50 Mg/50Ml Injectable Solution Vial, Nicotine 2 Mg Chewing Gum
05 Feb 2025
17 Feb 202524-1978**Methoxypolyentylene Glycol (Erythropoietin Beta 100 Mcg Each). 104691
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Erythropoietin, Excluding Epoetin Alfa, (Obo) Atc B03Xa01 For The Period 01.03.2025 - 28.02.2027
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Erythropoietin, Excluding Epoetin Alfa, (Obo) Atc B03Xa01 For The Period 01.03.2025 - 28.02.2027
Securing Drug Items For The E-Market Platform
Conclusion Of Non-Exclusive Discount Agreements According To §130A Para.8 Sgb V For Various Active Ingredients/Combinations With The Possibility Of Conclusion At Any Time Within The Framework Of The So-Called Open House Procedure
Conclusion Of Non-Exclusive Discount Agreements According To §130A Para.8 Sgb V For Various Active Ingredients/Combinations With The Possibility Of Conclusion At Any Time Within The Framework Of The So-Called Open House Procedure
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Erythropoietin (Atc Code B03Xa01).
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) For The Active Ingredient Erythropoietin (Exclusively Epoetin Zeta), (Obo), Atc B03Xa01 For The Period 01.12.2024 - 30.11.2026
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) For The Active Ingredient Erythropoietin (Exclusively Epoetin Zeta), (Obo), Atc B03Xa01 For The Period 01.12.2024 - 30.11.2026
Medicines Containing The Active Ingredient Erythropoietin (Atc: B03Xa01 - In The Strength Over 10,000 Iu Per Dosage Unit)
Medicines Containing The Active Ingredient Erythropoietin (Atc: B03Xa01 - In The Strength Up To 10,000 Iu Per Dosage Unit)
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Erythropoietin (B03Xa01) Within The Framework Of A So-Called Open-House Model.
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Erythropoietin (B03Xa01) Within The Framework Of A So-Called Open-House Model.
Conclusion Not Exclusive Of Am Discount Agreement According To Section 130A Paragraph 8 Sgb V By Means Of An Oh Model For Ws Epoetin Alfa (Genetically Engineered Human Erythropoietin - Restriction To Packs With Doses Up To 10,000 Iu)
Bidding For The Purchase Of 2 Medicine Items As Follows: 1. Erythropoietin Alfa Sterile Sol 40,000 Iu./Pre-Filled Syringe, Quantity 1,200 Syringe, 2. Hydroxyurea 500 Mg. Capsule, Quantity 180,000 Capsules, By Means Of Electronic Bidding.
Open House Drug Discount Agreements Erythropoietin Alfa, Atc B03Xa01
Open House Drug Discount Agreements Erythropoietin Alfa, Atc B03Xa01
Open House Drug Discount Agreements Erythropoietin Zeta, Atc B03Xa01
Open House Drug Discount Agreements Erythropoietin Zeta, Atc B03Xa01
Tenders by Country